Publications by authors named "Ippei Sato"

Claim this Profile
P
Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists.
Aiko Nitta, Yosuke Iura, Hideki Inoue, Ippei Sato, Koichiro Morihira

Bioorg Med Chem Lett· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
Aiko Nitta, Yosuke Iura, Hiroki Tomioka, Ippei Sato, Koichiro Morihira

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
Keiko Suzuki, Tatsuaki Morokata, Koichiro Morihira, Ippei Sato, Satoko Takizawa

Eur J Pharmacol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Tatsuaki Morokata, Keiko Suzuki, Yohei Masunaga, Katsunari Taguchi, Koichiro Morihira, Ippei Sato, Satoko Takizawa

J Pharmacol Exp Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.
Keiko Suzuki, Tatsuaki Morokata, Koichiro Morihira, Ippei Sato, Satoko Takizawa

Biochem Biophys Res Commun· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of 6-{4-[(3-fluorobenzyl)oxy]phenoxy}nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study.
Takahiro Kuramochi, Akio Kakefuda, Ippei Sato, Issei Tsukamoto, Taku Taguchi

Bioorg Med Chem· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger.
Takahiro Kuramochi, Akio Kakefuda, Hiroyoshi Yamada, Ippei Sato, Taku Taguchi

Bioorg Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis